(Makes clear in first paragraph that malaria is one part of
* $63 billion plan to include drugs and mosquito nets
* Greatly expands 2005 initiative
By Maggie Fox, Health and Science Editor
WASHINGTON, April 22 The U.S. government
announced on Thursday it would focus part of its $63 billion,
six-year Global Health Initiative plan to accelerate efforts to
fight malaria, mostly in Africa and aimed at women and
The goal is to reach 450 million people, or about 70
percent of the highest-risk populations in sub-Saharan Africa.
The plan is to use insecticide-treated nets, indoor insecticide
spraying, preventive treatment of pregnant women, and treatment
of infected people with artemisinin-based drug cocktails.
The work through the Global Health Initiative will keep
trying to integrate with each country's preferred approach to
fighting malaria, which infects 247 million people globally and
kills nearly one million a year, mostly children.
"The United States will invest $63 billion over six years
to help partner countries improve health outcomes, with a
particular focus on improving the health of women, newborns and
children," reads the report, issued by the U.S. Agency for
The full report is available at
A major goal is to affect most of Africa by cutting malaria
rates in half among the 450 million people targeted, the report
says. It also aims to limit the spread of malaria parasites
that resist treatment in Southeast Asia and the Americas.
The program will distribute nets and help spray against
mosquitoes that carry malaria parasites. But it will also try
to build public health capacity and also seek to integrate
anti-malaria efforts with work to combat AIDS, tuberculosis and
so-called neglected tropical diseases.
Without prompt treatment, malaria can cause severe illness,
coma and death. There is no vaccine but prophylactic drugs can
help prevent infection. So can efforts to eradicate
In 2005, the U.S. government released a five-year, $1.2
billion malaria initiative targeting 15 African countries.
The latest plan released expands on this, rolling out
anti-malaria efforts in the Democratic Republic of Congo and
Nigeria as well as up to seven additional countries.
"The selection of the seven additional countries will be
based on population, malaria burden, health infrastructure, and
availability of other donor funding," the report reads.
In March, the Roll Back Malaria Partnership said funding to
combat malaria must be more than tripled to be effective.
The group, backed by the World Health Organization, said
total annual funding was about $2 billion at the end of 2009,
but $6 billion a year was needed.
In the worst-hit countries, malaria takes up 90 percent of
public health spending. [ID:nSP459775]
Resistance to chloroquine and sulfadoxine-pyrimethamine,
the cheapest malaria drugs, is common. Artemisinin combination
therapy drugs made by firms like Novartis NOVN.VX and
Sanofi-Aventis (SASY.PA) can cost up to $11 over the counter.